Kensey Nash Extracts Biomaterials Growth To Curb Reliance On Angio-Seal
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash likely will pursue an acquisition strategy and an expanded client base to leverage its biomaterial patents and manufacturing capability